100 related articles for article (PubMed ID: 33214814)
1. Novel KIF18A Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2020 Nov; 11(11):2079-2080. PubMed ID: 33214814
[No Abstract] [Full Text] [Related]
2. Expression of KIF18A Is Associated with Increased Tumor Stage and Cell Proliferation in Prostate Cancer.
Zhang H; Shen T; Zhang Z; Li Y; Pan Z
Med Sci Monit; 2019 Aug; 25():6418-6428. PubMed ID: 31451680
[TBL] [Abstract][Full Text] [Related]
3. [Expression of KIF18A in gastric cancer and its association with prognosis].
Wang L; Yang S; Sun R; Lu M; Wu Y; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):585-9. PubMed ID: 27215532
[TBL] [Abstract][Full Text] [Related]
4. Novel KIF18A Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2020 Dec; 11(12):2368-2369. PubMed ID: 33335656
[No Abstract] [Full Text] [Related]
5. Novel Amide Compounds as KIF18A Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2021 May; 12(5):690-691. PubMed ID: 34055211
[No Abstract] [Full Text] [Related]
6. Synthesis and biological evaluation of optimized inhibitors of the mitotic kinesin Kif18A.
Braun J; Möckel MM; Strittmatter T; Marx A; Groth U; Mayer TU
ACS Chem Biol; 2015 Feb; 10(2):554-60. PubMed ID: 25402598
[TBL] [Abstract][Full Text] [Related]
7. High kinesin family member 18A expression correlates with poor prognosis in primary lung adenocarcinoma.
Li X; Liu M; Zhang Z; Zhang L; Liang X; Sun L; Zhong D
Thorac Cancer; 2019 May; 10(5):1103-1110. PubMed ID: 30907518
[TBL] [Abstract][Full Text] [Related]
8. KIF18A knockdown reduces proliferation, migration, invasion and enhances radiosensitivity of esophageal cancer.
Qian LX; Cao X; Du MY; Ma CX; Zhu HM; Peng Y; Hu XY; He X; Yin L
Biochem Biophys Res Commun; 2021 Jun; 557():192-198. PubMed ID: 33872988
[TBL] [Abstract][Full Text] [Related]
9. Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.
Alfarsi LH; Elansari R; Toss MS; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2019 Jan; 173(1):93-102. PubMed ID: 30306428
[TBL] [Abstract][Full Text] [Related]
10. Kinesin 18A expression: clinical relevance to colorectal cancer progression.
Nagahara M; Nishida N; Iwatsuki M; Ishimaru S; Mimori K; Tanaka F; Nakagawa T; Sato T; Sugihara K; Hoon DS; Mori M
Int J Cancer; 2011 Dec; 129(11):2543-52. PubMed ID: 21213216
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of KIF18A enhances cell proliferation and predicts poor survival in human clear cell renal carcinoma.
Chen QI; Cao B; Nan N; Wang YU; Zhai XU; Li Y; Chong T
Exp Ther Med; 2016 Jul; 12(1):377-383. PubMed ID: 27347065
[TBL] [Abstract][Full Text] [Related]
12. Targeted deletion of Kif18a protects from colitis-associated colorectal (CAC) tumors in mice through impairing Akt phosphorylation.
Zhu H; Xu W; Zhang H; Liu J; Xu H; Lu S; Dang S; Kuang Y; Jin X; Wang Z
Biochem Biophys Res Commun; 2013 Aug; 438(1):97-102. PubMed ID: 23872115
[TBL] [Abstract][Full Text] [Related]
13. Kif18A is involved in human breast carcinogenesis.
Zhang C; Zhu C; Chen H; Li L; Guo L; Jiang W; Lu SH
Carcinogenesis; 2010 Sep; 31(9):1676-84. PubMed ID: 20595236
[TBL] [Abstract][Full Text] [Related]
14. The regulation of MS-KIF18A expression and cross talk with estrogen receptor.
Zusev M; Benayahu D
PLoS One; 2009 Jul; 4(7):e6407. PubMed ID: 19636373
[TBL] [Abstract][Full Text] [Related]
15. MS-KIF18A, a kinesin, is associated with estrogen receptor.
Luboshits G; Benayahu D
J Cell Biochem; 2007 Feb; 100(3):693-702. PubMed ID: 17006958
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
[TBL] [Abstract][Full Text] [Related]
17. The role of kinesin KIF18A in the invasion and metastasis of hepatocellular carcinoma.
Luo W; Liao M; Liao Y; Chen X; Huang C; Fan J; Liao W
World J Surg Oncol; 2018 Feb; 16(1):36. PubMed ID: 29466986
[TBL] [Abstract][Full Text] [Related]
18. Sumoylation of Kif18A plays a role in regulating mitotic progression.
Yang F; Chen Y; Dai W
BMC Cancer; 2015 Mar; 15():197. PubMed ID: 25884224
[TBL] [Abstract][Full Text] [Related]
19. High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma.
Liao W; Huang G; Liao Y; Yang J; Chen Q; Xiao S; Jin J; He S; Wang C
Oncotarget; 2014 Nov; 5(21):10271-9. PubMed ID: 25431949
[TBL] [Abstract][Full Text] [Related]
20. A tethering mechanism controls the processivity and kinetochore-microtubule plus-end enrichment of the kinesin-8 Kif18A.
Stumpff J; Du Y; English CA; Maliga Z; Wagenbach M; Asbury CL; Wordeman L; Ohi R
Mol Cell; 2011 Sep; 43(5):764-75. PubMed ID: 21884977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
